Samsung BioLogics signed a contract with Moderna on the 22nd (local time) to commission the production of COVID-19 vaccines. After producing undiluted corona vaccine abroad, Samsung BioLogics will charge and pack it in Korea.

Samsung BioLogics CEO John Lim and CEO Stéphane Bancel Moderna attended the "Korea-U.S. Vaccine Company Cooperation Event" held in Washington, D.C. on the same day and signed the same day. Samsung BioLogics plans to start aseptic charging, labeling, and packaging of hundreds of millions of vaccines to markets outside the U.S. starting in the third quarter.

"The Moderna vaccine is the most important vaccine for people around the world fighting COVID-19," said Jo